Suchergebnisse - "Lam, Stella"

PubPharm (17)

1

Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy

enthalten in: Clinical chemistry | 2020

von Lin, S. | Chang, S. | Lam, S. | +11

2

Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Iida, Y. | Ciechanover, A. | Marzese, D. | +13

3

Correction : Ono, S.; Lam, S.; Nagahara, M.; Hoon, D.S.B. Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays. J. Clin. Med. 2015, 4, 1890-1907

enthalten in: Journal of clinical medicine | 2016

von Ono, S. | Lam, S. | Nagahara, M. | +1

ErratumFor: J Clin Med. 2015;4(10):1890-907. - PMID 26512704

4

Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients : Pros and Cons of Current Assays

enthalten in: Journal of clinical medicine | 2015

von Ono, S. | Lam, S. | Nagahara, M. | +1

ErratumIn: J Clin Med. 2016;5(9). pii: E81. doi: 10.3390/jcm5090081. - PMID 27626450

5

A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients

enthalten in: Oncotarget | 2015

von Ono, S. | Oyama, T. | Lam, S. | +3

6

RASAL2 activates RAC1 to promote triple-negative breast cancer progression

enthalten in: The Journal of clinical investigation | 2014

von Feng, M. | Bao, Y. | Li, Z. | +9

7

Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2014

von Kiyohara, E. | Hata, K. | Lam, S. | +1

8

Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC : a retrospective analysis with follow-up for 12 years

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2013

von Paidpally, V. | Tahari, A. | Lam, S. | +5

9

Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years

enthalten in: Journal of nuclear medicine | 2013

von Paidpally, V. | Tahari, A. | Lam, S. | +5

10

FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma

enthalten in: Imaging in medicine | 2012

von Paidpally, V. | Chirindel, A. | Lam, S. | +3